On the call are Rene Haas, Arm Holdings plc American Depositary Shares' Chief Executive, and Jason Child, Arm Holdings plc ...

The Alliance for Regenerative Medicine (ARM), the advocacy voice for regenerative medicine, issued the following statement about the FDA's release of a clinical hold on Geron's human embryonic stem ...

Qualcomm 's central processors are properly licensed under an agreement with Arm Holdings, a jury found in a trial in U.S. federal court that removed some, but not all, uncertainty around the mobile ...

With the end of testimony on day 3 of the Qualcomm/Arm trial, the only items remaining were the closing arguments, instructions for the jury and their deliberations. The jury didn’t reach a verdict ...

Arm dominates mobile chip architecture through licensing/royalties but faces rising competition from RISC-V and potential customer defection, as major tech companies develop in-house solutions. $500B ...